Follow-Up of Patients After Total Pancreatectomy and Islet Cell Autotransplantation at Off-Site Islet Isolation Facility
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgac674 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Saloni U Lad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Islets of Langerhans Transplantation, Islets of Langerhans, Pancreatitis, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH.
Abstract (Originalsprache)
Context
Total pancreatectomy with islet autotransplantation (TPIAT) is a definitive management for intractable pain in patients with chronic pancreatitis (CP). Islet autotransplantation (IAT) allows for the preservation of beta cells to prevent complications of long-term diabetes.
Objective
Our study follows TPIAT recipients for up to 12 years to determine the efficacy of the procedure completed with an off-site islet isolation facility.
Methods
Patient demographics, mixed meal tolerance test measures, glycosylated hemoglobin, insulin requirements, and homeostatic model assessment for insulin resistance values were collected prior to surgery and at the most recent follow-up assessment.
Results
Forty-four patients (median age, 46.0 years; range, 20-78 years) underwent TPIAT for CP. At an overall median follow-up time of 845.5 days (range, 195-4470 days) 8 patients were insulin independent and 36 patients were insulin dependent. At the most recent follow-up time point, islet yield per kilogram was the strongest indicator of insulin independence. Homeostatic model assessment for insulin resistance values were comparable between insulin independent and dependent cohorts.
Conclusions
Our long-term follow-up data suggest that IAT can effectively reduce insulin requirements and improve postoperative glycemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.
- Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
- Department of Medicine, Royal College of Surgeons in Ireland-Medical University of Bahrain, Muharraq, Bahrain.
- Department of Medicine, Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
- Division of Endocrinology and Diabetes, Macromedica Dominicana, Santo Domingo, Dominican Republic.
- Institute for Cellular Therapeutics, Allegheny Health Network Research Institute, Pittsburgh PA 15222, USA.
ORCID-Profile: Saloni U Lad, Vicente T San Martin, Rita Bottino, Yu Kuei Lin, R Matthew Walsh, Betul Hatipoglu
Förderung
- NIDDK NIH HHS
- NIH
Zitieren
APA
Lad, S. U., Ali, K. F., Johnston, P. C., San Martin, V. T., Bottino, R., Lin, Y. K., Walsh, R. M., Stevens, T., Tu, C., & Hatipoglu, B. (2023). Follow-Up of Patients After Total Pancreatectomy and Islet Cell Autotransplantation at Off-Site Islet Isolation Facility. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac674
Vancouver
Lad SU, Ali KF, Johnston PC, San Martin VT, Bottino R, Lin YK, et al. Follow-Up of Patients After Total Pancreatectomy and Islet Cell Autotransplantation at Off-Site Islet Isolation Facility. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgac674
BibTeX
@article{Lad2023,
author = {Lad, Saloni U and Ali, Khawla F and Johnston, Philip C and San Martin, Vicente T and Bottino, Rita and Lin, Yu Kuei and Walsh, R Matthew and Stevens, Tyler and Tu, Chao and Hatipoglu, Betul},
title = {Follow-Up of Patients After Total Pancreatectomy and Islet Cell Autotransplantation at Off-Site Islet Isolation Facility},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgac674}
}
EUVIMED